Aziridine‐2,3‐dicarboxylates and N ‐acylated derivatives have been evaluated as potential irreversible inhibitors of the cysteine proteinase papain. Dependence of inhibition activity on stereo‐chemistry of the aziridine moiety has been analyzed. Whereas unsubstituted ( R , R )‐ and ( S , S )‐ diethyl aziridine‐2,3‐dicarboxylates ( 5 ) and ( 2 ) show no significant difference in inactivation the derivative acylated with BOC‐( S )‐Phe (BOC‐( S )‐Phe‐( S , S )‐Azi) ( 10 ) shows a 6 fold higher activity than the diastereomer BOC‐( S )‐Phe‐( R , R )‐Azi ( 11 ). Analogs acylated with Z‐ or BOC‐( S )‐Ala ( 9, 8 ) have lower second‐order rate constants, indicating binding of the amino acid moiety of the inhibitors to the S2 subsite of the enzyme.
No takes yet. Share an insight, caveat, or question.
Tanja Schirmeister (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: